SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: mph who wrote (1002)11/9/1998 6:44:00 AM
From: Henry Niman  Respond to of 1722
 
PFE's SERMs are listed at Ligand's Clinical Trials page at biocognizance.com



To: mph who wrote (1002)11/10/1998 7:58:00 AM
From: Henry Niman  Respond to of 1722
 
Here's what Bear Stearns had to say today about PFE's SERMs:

"Droloxifene-SERM (Selective Estrogen Receptor Modulator).
Development is pushed back as PFE wants to develop a very potent
and safe compound. A second compound seems to be more potent and
either or both may enter Phase 3 trials next year."